Analysts expect Corcept Therapeutics Inc to report revenue of 315.89 M for Q3 26, against a range of 289.31 M to 342.46 M. The most recent reported quarter, Q2 26, came in at 256.15 M, a 12.9% beat against the 226.94 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 182.55 M | 181.89 M | 157.21 M | 194.43 M | 207.64 M | 202.13 M | 164.90 M | 256.15 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 184.61 M | 197.97 M | 200.74 M | 202.12 M | 247.44 M | 256.29 M | 206.67 M | 235.40 M | 342.46 M | 380.39 M | 351.60 M | 434.90 M | 453.92 M | 559.43 M | 429.94 M | 559.09 M | ||||||||||
| Low Estimate | 167.31 M | 182.46 M | 170.32 M | 173.30 M | 218.17 M | 228.65 M | 172.29 M | 218.47 M | 289.31 M | 334.28 M | 328.65 M | 387.53 M | 427.07 M | 461.22 M | 374.00 M | 493.17 M | ||||||||||
| Consensus Estimate | 175.96 M | 190.22 M | 185.53 M | 187.71 M | 232.80 M | 242.47 M | 189.48 M | 226.94 M | 315.89 M | 357.33 M | 340.13 M | 411.21 M | 440.50 M | 510.33 M | 401.97 M | 526.13 M |
Analysts expect Corcept Therapeutics Inc to report earnings per share of 0.85 for Q3 26, against a range of 0.81 to 0.89. The most recent reported quarter, Q2 26, came in at 0.36 , in line with the 0.02 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.41 | 0.26 | 0.17 | 0.29 | 0.16 | 0.20 | -0.30 | 0.36 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.30 | 0.48 | 0.16 | 0.22 | 0.15 | 0.32 | -0.09 | 0.02 | 0.89 | 1.21 | 0.89 | 1.30 | 1.33 | 1.73 | 1.43 | 1.84 | ||||||||||
| Low Estimate | 0.28 | 0.44 | 0.14 | 0.18 | 0.15 | 0.30 | -0.11 | 0.02 | 0.81 | 1.03 | 0.81 | 1.10 | 1.17 | 1.47 | 1.33 | 1.64 | ||||||||||
| Consensus Estimate | 0.29 | 0.46 | 0.15 | 0.20 | 0.15 | 0.31 | -0.10 | 0.02 | 0.85 | 1.12 | 0.85 | 1.20 | 1.25 | 1.60 | 1.38 | 1.74 |
Pull Wall Street consensus for Corcept Therapeutics Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CORT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CORT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CORT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();